U.S. INDUSTRY &
WORKFORCE NEWS

REAL STORIES. REAL WORKERS. REAL STRENGTH.

Monday, November 16, 2026

Pfizer to Invest $650 Million in Connecticut Manufacturing Center

Pharmaceutical giant Pfizer plans a $650 million investment to build a 220,000-square-foot Manufacturing Technology Center at its Groton, Connecticut campus to support global clinical trials.

Pfizer announced a major investment of $650 million over the next five years to construct a new 220,000-square-foot Manufacturing Technology Center at its research and development campus in Groton, Connecticut. The facility is designed to produce clinical active pharmaceutical ingredients and drug products for Pfizer-sponsored clinical trials worldwide.

Construction of the center is expected to begin in the second quarter of 2027, with operations targeted to start by mid-2031. The new manufacturing hub will consolidate employees and operations that are currently dispersed across Pfizer’s Groton campus.

This investment underscores Pfizers strategy to expand its clinical manufacturing capabilities in the United States, providing critical infrastructure to support its development pipeline. Although no Connecticut state funding has been allocated for the project so far, the company may seek incentives in the future.

Local officials anticipate that the construction of the center will generate jobs in the region, supporting the areas workforce and economic growth. However, Pfizer has not disclosed whether the facility will create additional permanent jobs once operational.

The Groton Manufacturing Technology Center highlights Pfizers continued commitment to maintaining advanced pharmaceutical production capacity on U.S. soil, which is vital for the resilience of supply chains and the speed of drug development and delivery.

Search American Industries News